Breast cancer-associated antibody LU BCRU G7 recognises the terminal disaccharide Gal beta 1-3GlcNAc and can be used to isolate tumour cells from body fluids by an immunomagnetic bead procedure.
Rye
P D
PD
Department of Tumour Biology, Norwegian Radium Hospital, Oslo, Norway.
Bovin
N V
NV
Vlasova
E
E
Høifødt
H K
HK
Kierulf
B
B
Trones
G E
GE
Fodstad
O
O
D000117:Acetylglucosamine / Q000031:analogs & derivatives* / Q000276:immunology; D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D001826:Body Fluids / Q000166:cytology; D001943:Breast Neoplasms / Q000276:immunology* / Q000473:pathology; D005260:Female; D006801:Humans; D018189:Immunomagnetic Separation / Q000379:methods*
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; C033398:galactosyl-1,3-N-acetylglucosamine; D000117:Acetylglucosamine